{"Abstract": [0], "N": [1], "6": [2], "-methyladenosine": [3], "(m6A)": [4], "is": [5, 25, 55], "the": [6, 28, 46, 88, 109, 130, 134, 168], "most": [7], "prevalent,": [8], "abundant": [9], "and": [10, 41, 52, 63, 83, 90, 111, 118, 133, 144], "conserved": [11], "internal": [12], "cotranscriptional": [13], "modification": [14, 24, 76], "in": [15, 80, 87, 128, 151, 167], "eukaryotic": [16, 21], "RNAs,": [17], "especially": [18, 86], "within": [19], "higher": [20], "cells.": [22], "m6A": [23, 29, 74, 104, 139, 157], "modified": [26], "by": [27, 45, 57], "methyltransferases,": [30], "or": [31, 48], "writers,": [32], "such": [33], "as": [34, 67], "METTL3/14/16,": [35], "RBM15/15B,": [36], "ZC3H3,": [37], "VIRMA,": [38], "CBLL1,": [39], "WTAP,": [40], "KIAA1429,": [42], "and,": [43], "removed": [44], "demethylases,": [47], "erasers,": [49], "including": [50], "FTO": [51], "ALKBH5.": [53], "It": [54], "recognized": [56], "m6A-binding": [58], "proteins": [59], "YTHDF1/2/3,": [60], "YTHDC1/2": [61], "IGF2BP1/2/3": [62], "HNRNPA2B1,": [64], "also": [65], "known": [66], "\u201creaders\u201d.": [68], "Recent": [69], "studies": [70], "have": [71], "shown": [72], "that": [73, 156], "RNA": [75, 105, 140, 158], "plays": [77], "essential": [78], "role": [79], "both": [81, 108], "physiological": [82, 110], "pathological": [84, 112], "conditions,": [85], "initiation": [89], "progression": [91, 150], "of": [92, 95, 114, 138], "different": [93], "types": [94], "human": [96], "cancers.": [97], "In": [98], "this": [99], "review,": [100], "we": [101], "discuss": [102], "how": [103], "methylation": [106, 159], "influences": [107], "progressions": [113], "hematopoietic,": [115], "central": [116], "nervous": [117], "reproductive": [119], "systems.": [120, 153], "We": [121, 154], "will": [122], "mainly": [123], "focus": [124], "on": [125], "recent": [126], "progress": [127], "identifying": [129], "biological": [131], "functions": [132], "underlying": [135], "molecular": [136], "mechanisms": [137], "methylation,": [141], "its": [142], "regulators": [143], "downstream": [145], "target": [146], "genes,": [147], "during": [148], "cancer": [149, 165], "above": [152], "propose": [155], "process": [160], "offer": [161], "potential": [162], "targets": [163], "for": [164], "therapy": [166], "future.": [169]}